Astria Therapeutics, Inc. (ATXS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	20.9	19.7	19.2	18.4	17.8	17.0	14.8	14.2
General and administrative	20.9	19.7	19.2	18.4	17.8	17.0	14.8	14.2
Research and development	34.4	31.9	34.3	30.4	26.5	23.3	15.6	15.6
Other operating expenses							0.9
EBIT [+]	-55.3	-51.6	-53.5	-49.6	-45.1	-41.1	-31.2	-29.8
EBIT growth	22.6%	25.5%	71.3%	66.2%	37.5%	18.0%	-16.6%	-15.3%
Non-recurring items							163.7
Interest income	6.3	4.0	1.7	0.7	0.3	0.2	0.1	0.1
Interest income	6.3	4.0	1.7	0.7	0.3	0.2	0.1	0.1
Other income (expense), net	-0.1	-0.1	-0.1	-0.1	0.0	0.0	-0.1	0.0
Pre-tax income	-49.0	-47.7	-51.8	-48.1	-43.9	-40.2	-194.9	-194.4
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-49.0	-47.7	-51.8	-48.1	-43.9	-64.6	-219.3	-218.8

Basic EPS [+]	($2.32)	($2.75)	($3.81)	($3.95)	($3.68)	($6.34)	($27.88)	($34.19)
Growth	-36.8%	-56.6%	-86.3%	-88.5%	-93.4%	-77.8%	650.6%	1082.0%
Diluted EPS [+]	($2.32)	($2.75)	($3.81)	($3.95)	($3.68)	($6.34)	($27.88)	($34.19)
Growth	-36.8%	-56.6%	-86.3%	-88.5%	-93.4%	-77.8%	650.6%	1082.0%

Shares outstanding (basic) [+]	21.1	17.3	13.6	12.2	11.9	10.2	7.9	6.4
Growth	76.5%	70.1%	72.9%	90.2%	198.6%	45.6%	-21.7%	-47.0%
Shares outstanding (diluted) [+]	21.1	17.3	13.6	12.2	11.9	10.2	7.9	6.4
Growth	76.5%	70.1%	72.9%	90.2%	198.6%	45.6%	-21.7%	-47.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.